These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 11896503)

  • 41. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
    Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary aldosteronism--careful investigation is essential and rewarding.
    Stowasser M; Gordon RD
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):33-9. PubMed ID: 15134798
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism.
    Bernini G; Moretti A; Orlandini C; Berti P; Miccoli P; Bardini M; Taurino C; Bernini M; Salvetti A
    J Hypertens; 2008 May; 26(5):981-8. PubMed ID: 18398341
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism.
    Jansen PM; van den Born BJ; Frenkel WJ; de Bruijne EL; Deinum J; Kerstens MN; Smulders YM; Woittiez AJ; Wijbenga JA; Zietse R; Danser AH; van den Meiracker AH
    J Hypertens; 2014 Jan; 32(1):115-26. PubMed ID: 24018605
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives.
    Rossi E; Regolisti G; Negro A; Sani C; Davoli S; Perazzoli F
    Am J Hypertens; 2002 Oct; 15(10 Pt 1):896-902. PubMed ID: 12372677
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of hyperaldosteronism in primary care patients with resistant hypertension.
    Schmiemann G; Gebhardt K; Hummers-Pradier E; Egidi G
    J Am Board Fam Med; 2012; 25(1):98-103. PubMed ID: 22218630
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary hyperaldosteronism: a missed diagnosis in 'essential hypertensives'?
    Brown MA; Cramp HA; Zammit VC; Whitworth JA
    Aust N Z J Med; 1996 Aug; 26(4):533-8. PubMed ID: 8873937
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Primary aldosteronism].
    Fardella CE; Mosso LM; Carvajal CA
    Rev Med Chil; 2008 Jul; 136(7):905-14. PubMed ID: 18949169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The accuracy of combining aldosterone to renin ratio and low renin level in diagnosing primary aldosteronism].
    Li F; Xie XY; Zhao TY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 May; 41(3):501-4, 517. PubMed ID: 20629332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of primary hyperaldosteronism in a systemic arterial hypertension league.
    Ribeiro MJ; Figueiredo Neto JA; Memória EV; Lopes Mde C; Faria Mdos S; Salgado Filho N; Oliveira TC
    Arq Bras Cardiol; 2009 Jan; 92(1):39-45. PubMed ID: 19219263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The serum sodium to urinary sodium to (serum potassium)2 to urinary potassium (SUSPPUP) ratio in patients with primary aldosteronism.
    Willenberg HS; Kolentini C; Quinkler M; Cupisti K; Krausch M; Schott M; Scherbaum WA
    Eur J Clin Invest; 2009 Jan; 39(1):43-50. PubMed ID: 19067735
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The influence of serum aldosterone and the aldosterone-renin ratio on pulse wave velocity in hypertensive patients.
    Park S; Kim JB; Shim CY; Ko YG; Choi D; Jang Y; Chung N
    J Hypertens; 2007 Jun; 25(6):1279-83. PubMed ID: 17563542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The renin-angiotensin-aldosterone system in primary and secondary hypertension.
    del Greco F; Huang CM; Quintanilla A; Krumlovsky F; Roxe DM; Santhanam S
    Ann Clin Lab Sci; 1981; 11(6):497-505. PubMed ID: 6119955
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hypertension and mineralocorticoids. Usefulness of renin and aldosterone measurements].
    Fardella CE; Montero J; Mosso L
    Rev Med Chil; 1999 May; 127(5):604-10. PubMed ID: 10451632
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reliability of a Bayesian network to predict an elevated aldosterone-to-renin ratio.
    Ducher M; Mounier-Véhier C; Lantelme P; Vaisse B; Baguet JP; Fauvel JP
    Arch Cardiovasc Dis; 2015 May; 108(5):293-9. PubMed ID: 25858535
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detecting and treating primary aldosteronism: primary aldosteronism.
    Mantero F; Mattarello MJ; Albiger NM
    Exp Clin Endocrinol Diabetes; 2007 Mar; 115(3):171-4. PubMed ID: 17427105
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.
    Schwartz GL; Turner ST
    Clin Chem; 2005 Feb; 51(2):386-94. PubMed ID: 15681560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High frequency of primary hyperaldosteronism among hypertensive patients from a primary care area in Sweden.
    Westerdahl C; Bergenfelz A; Isaksson A; Wihl A; Nerbrand C; Valdemarsson S
    Scand J Prim Health Care; 2006 Sep; 24(3):154-9. PubMed ID: 16923624
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol.
    Giacchetti G; Ronconi V; Lucarelli G; Boscaro M; Mantero F
    J Hypertens; 2006 Apr; 24(4):737-45. PubMed ID: 16531803
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Primary hyperaldosteronism in hypertension].
    Girerd X
    Rev Med Suisse; 2008 Sep; 4(170):1924-6. PubMed ID: 18847121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.